Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for IPOPEMA Securities's Net Cash per Share or its related term are showing as below:
WAR:IPE's Price-to-Net-Cash is not ranked *
in the Capital Markets industry.
Industry Median: 5.64 * Ranked among companies with meaningful Price-to-Net-Cash only.
IPOPEMA Securities (WAR:IPE) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
IPOPEMA Securities Net Cash per Share Related Terms
IPOPEMA Securities Net Cash per Share Historical Data
* Premium members only.
The historical data trend for IPOPEMA Securities's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:IPE vs MS, GS, SCHW: Net Cash per Share Comparison
For the Capital Markets subindustry, IPOPEMA Securities's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IPOPEMA Securities Price-to-Net-Cash vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, IPOPEMA Securities's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where IPOPEMA Securities's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
IPOPEMA Securities's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IPOPEMA Securities (WAR:IPE) has a Net Cash per Share of zł-14.16 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on IPOPEMA Securities and its competitors. According to the industry distribution chart, IPOPEMA Securities ranks #999999 out of 219 companies in the Capital Markets industry.
Is IPOPEMA Securities' Net Cash per Share too high?
IPOPEMA Securities' current Net Cash per Share is zł-14.16. Based on the distribution chart, IPOPEMA Securities ranks #999999 out of 219 companies in the Capital Markets industry, which is in the bottom quartile relative to peers. Overall, IPOPEMA Securities has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IPOPEMA Securities' Net Cash per Share compare to MS and GS?
According to the Capital Markets industry distribution chart, IPOPEMA Securities ranks #999999 out of 219 companies for Net Cash per Share. This places IPOPEMA Securities in the lower half of its industry. The industry median Net Cash per Share is 5.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Capital Markets company?
The median Net Cash per Share among Capital Markets companies is 5.64, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on IPOPEMA Securities and its competitors. For the Capital Markets industry, the median Net Cash per Share is 5.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IPOPEMA Securities's current Net Cash per Share is zł-14.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IPOPEMA Securities stock overvalued right now?
Based on GuruFocus' analysis, IPOPEMA Securities (WAR:IPE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł3.63, compared to a current price of zł9.08 — trading 150.1% above its estimated fair value. The current Net Cash per Share is zł-14.16. IPOPEMA Securities' overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For IPOPEMA Securities (WAR:IPE), the current Net Cash per Share is zł-14.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IPOPEMA Securities (WAR:IPE) Overvalued in 2026?
Based on GuruFocus' analysis, IPOPEMA Securities stock appears to be overvalued.
The current stock price of zł9.08 is trading 150.1% above its estimated GF Value™ of zł3.63.
GuruFocus considers IPOPEMA Securities to be Significantly Overvalued.
Key valuation signals for WAR:IPE:
Net Cash per Share: zł-14.16
GF Value™: zł3.63 vs. price of zł9.08 (150.1% above fair value)
No single metric tells the full story. See the WAR:IPE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IPOPEMA Securities SA is focused on brokerage activities, Business and management consulting, running an investment fund company and creating and managing investment funds, Management of portfolios of brokerage financial instruments, IT management activities, and IT consulting activities. It specializes in brokerage and company analysis services, investment banking services, as well as the distribution of investment products and investment advisory services addressed to a wide range of individual investors, the creation and management of closed-end and open-end investment funds and asset management, as well as business and IT consulting services.
56GF Score
Get the complete analysis for WAR:IPE
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:IPE has been successfully added to your 
